We analysed STAT5A gene expression in breast cancer using the Oncomine database. We exemplify four representative studies showing that STAT5A is generally downregulated in breast cancer.
a b s t r a c t
We analysed STAT5A gene expression in breast cancer using the Oncomine database. We exemplify four representative studies showing that STAT5A is generally downregulated in breast cancer.
& We show that in different independent studies STAT5A is downregulated in breast cancer. The downregulation of STAT5A supports a tumour suppressor role for STAT5A in breast cancer and is consistent with our recent discovery that STAT5A is a p53-target gene [2] .
High levels of STAT5A indicate a good prognosis in breast cancer and it assessment can be used in the clinics as part of a multigene prognostic test (Fig. 1) . 
Data
We show that STAT5A is downregulated in breast cancer using several large-scale gene expression analyses available at Oncomine: https://www.oncomine.org/resource/main.html [1] .
Experimental design, materials and methods
We used the publicly available Oncomine search to find the status of STAT5A in breast cancer.
